These investigators pointed out the concept of intercellular transfer of receptors, where EVs in RA patients transfer their transporters (possibly microRNAs) to cells in the microenvironment, involving the development of T-cell exhaustion and the transfer of the co-suppressor receptor PD-1, thus increasing the chronic development of these patients. The gene discussed is PDCD1; the disease is rheumatoid arthritis.